Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.73 | 38.47 |
| PEG Ratio (TTM) | -0.99 | 3.18 |
| P/S Ratio (TTM) | 0.92 | 4.24 |
| P/B Ratio (TTM) | 0.95 | 4.30 |
| P/FCF Ratio (TTM) | 10.94 | 33.20 |
| Price to 5YR AVG Earnings Ratio | 13.70 | 78.52 |
| Price to 5YR AVG FCF Ratio | 16.87 | 46.42 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.54% | 3.41% |
| ROE (TTM) | 6.42% | 15.20% |
| Net Profit Margin (TTM) | 6.30% | 10.68% |
| ROIC 5YR AVG | 12.64% | 13.56% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.50% | 9.40% | 15.48% |
| Revenue | -3.79% | 2.52% | 3.91% |
| Net Income | -9.74% | 9.97% | 15.91% |
| Cash Flow | 13.21% | -1.15% | 6.80% |
Health (84%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.67 | 2.16 |
| Quick Ratio (TTM) | 1.68 | 1.46 |
| D/E Ratio (TTM) | 0.18 | 0.60 |
| Interest Coverage (TTM) | 10.70 | -16.83 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 3.31 | 5.33 |
| LTL to 5YR AVG FCF | 1.75 | 4.80 |
| Shares Outstanding Growth 5YR AVG | 0.20% | 5.54% |